SAN DIEGO--(BUSINESS WIRE)--Dexcom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, commends the expansion of CGM Medicare coverage to ...
DexCom (NasdaqGS:DXCM) has launched Dexcom Flex, a new continuous glucose monitoring system for Type 2 diabetes patients who ...
Add Yahoo as a preferred source to see more of our stories on Google. (COLORADO SPRINGS) — A medical device for diabetes called the Dexcom is facing a national shortage that’s now leaving diabetics in ...
SAN DIEGO--(BUSINESS WIRE)--This World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), the global leader in glucose biosensing technology, is encouraging people with diabetes globally to take the first ...
Diabeloop, a pioneer in therapeutic artificial intelligence for diabetes management, today announced technical ...
Dexcom has announced a new continuous glucose monitoring system designed for people using basal insulin, oral therapies or GLP-1 receptor agonists1. The new system will be available shortly. Dexcom ...
Zacks Investment Research on MSN
DXCM to launch Dexcom Flex CGM system for type 2 diabetes in Germany
DexCom DXCM recently announced the launch of Dexcom Flex, a new continuous glucose monitoring (CGM) system designed for ...
San Diego’s Dexcom began sales this week of Stelo, the industry’s first FDA-approved continuous glucose monitor that doesn’t require a prescription. With a two-pack of the biosensor costing just under ...
Join the event trusted by enterprise leaders for nearly two decades. VB Transform brings together the people building real enterprise AI strategy. Learn more About one in three Americans, or 125 ...
It's no secret that helping patients manage diabetes has become a huge market. That's to be expected, since more than 1 out of 10 Americans suffer from the chronic disease. Individuals with diabetes ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results